Gyala, Therapeutics

Gyala Therapeutics inicia un ensayo clínico de fase I/ IIa de una terapia con células CAR-T

Veröffentlicht: 17.03.2026 um 20:15 Uhr, prnewswire.co.uk

Gyala Therapeutics Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom United States of America

View original content:https://www.prnewswire.com/news-releases/gyala-therapeutics-inicia-un-ensayo-clinico-de-fase-iiia-de-una-terapia-con-celulas-car-t-302681620.html

en | boerse | 68735187 |